SAEs, Non-Response With Obeticholic Acid in Cirrhosis With PBC SAEs, Non-Response With Obeticholic Acid in Cirrhosis With PBC

This study aimed to determine predicting factors of hepatic serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis undergoing obeticholic acid therapy.Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news